Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Elon Musk is on weight loss drug bandwagon
Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.
Age and the new weight-loss drugs
Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?
Obesity rates are down. Is that because of weight-loss drugs?
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the NHANES results found two instances of slight decreases in obesity rates and two dips in severe obesity rates. These falls were followed by steady increases in both categories.
Elon Musk shows support for weight loss drugs despite RFK Jr.'s criticism
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.
Elon Musk is on the weight loss drug bandwagon
Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency (DOGE), is doubling down on his support for expanding access to affordable GLP-1 weight-loss medications like Ozempic.
Elon Musk reveals support for drugs like Ozempic — in direct contrast to Trump’s HHS pick RFK Jr.
Elon Musk, one of President-elect Donald Trump’s closest confidants, revealed Wednesday his support for weight-loss drugs like Ozempic being made cheaper for the general public — in contrast with comments Health and Human Services Secretary-designate Robert F.
7h
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound ...
1h
on MSN
Lifestyle News Live Today December 12, 2024: Woman lost impressive amount of arm and back fat without any stretch marks or loose skin with this simple home workout
Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...
7d
In new trial, Zepbound bests Wegovy for weight loss
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
Science Daily
3d
Diet and Weight Loss News
Nov. 26, 2024 — Tirzepatide, a new injectable
weight
-
loss
drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...
7d
on MSN
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
8d
Gastric balloon being tested as alternative to weight-loss surgery, GLP-1 meds
Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
HealthDay on MSN
6d
Weight loss may bring big healthcare savings to Americans
Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
7d
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
2d
‘Lifting from head to toe’: Weight-loss drugs boost popularity of surgeries to remove extra skin
Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Elon Musk
Eli Lilly
Ozempic
Zepbound
Josh Mankiewicz
Feedback